Lung Cancer Awareness Month
November 5, 2019
Who’s Caring for the Caregivers?
November 26, 2019
Show all

Skin in the Game

With November being Healthy Skin Month, it’s the perfect time to give some extra attention to issues facing those with psoriasis.

With November being Healthy Skin Month, it’s the perfect time to give some extra attention to issues facing those with psoriasis. There are nearly 7.5 million Americans living with the dry, scaly, painful patches of skin typical of psoriasis. The most likely areas affected by psoriasis include skin around joints, face, neck, trunk, arms, hands, feet, and scalp.

Although there are a growing number of medication choices for managing psoriasis symptoms, a cure remains out of reach. Psoriasis can lead to far more health concerns than dry skin. Nearly one-third of those with psoriasis will later develop psoriatic arthritis. In addition, the presence of psoriasis is associated with a higher risk of diabetes, heart disease, and depression.

Psoriasis also correlates to skin cancer, in that patients with psoriasis have a 1.53-fold greater risk of developing melanoma or a hematologic cancer when compared to individuals without psoriasis. This connection with skin cancer was found to be even stronger as the severity of psoriasis increased. Current thinking holds that the inflammation involved with psoriasis serves as a contributor to skin cancer.

There are steps anyone can take to lower the risk of skin cancer such as: using sunscreen diligently, staying out of the sun during peak hours, never using tanning beds, and checking skin for any suspicious moles. Furthermore, it makes sense, for a variety of reasons, to enact a treatment plan to address psoriasis symptoms.

Read on: [wp_colorbox_media url=”https://bioplussp.com/2019/11/12/skin-in-the-game/” type=”iframe” hyperlink=”Skin in the Game”]

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.